Cytek Biosciences, Inc. 8-K

What Happened
On May 7, 2026, Cytek Biosciences, Inc. (CTKB) announced its financial results for the quarter ended March 31, 2026 and furnished the related press release as Exhibit 99.1 in a Form 8-K (Item 2.02: Results of Operations and Financial Condition). The 8-K indicates the company reported its quarterly results publicly via that press release.

Key Details

• Filing date: May 7, 2026 (Form 8-K filed with the SEC).
• Period covered: quarter ended March 31, 2026.
• Disclosure: Press release containing the quarterly results furnished as Exhibit 99.1.
• The filing also included the Inline XBRL cover page (Exhibit 104) for interactive data.

Why It Matters
Quarterly results provide the key revenue, earnings and operating information investors use to assess company performance and short-term outlook. This 8-K notifies investors that Cytek has released its latest quarterly earnings information; investors should review the furnished press release (Exhibit 99.1) and any subsequent filings or investor materials for the specific revenue, profit/loss, and management commentary that could affect the stock.